In vivo inhibition of renal 11beta-hydroxysteroid dehydrogenase in the rat stimulates collecting duct sodium reabsorption.
In order to test the proposal that the aldosterone specificity of mineralocorticoid receptors in the collecting duct depends on inactivation of glucocorticoids by the enzyme 11beta-hydroxysteroid dehydrogenase (11beta-HSD), we have assessed the effect of pharmacological inhibition of 11beta-HSD on collecting duct Na+ reabsorption in vivo. Adrenalectomized rats (n=14) were infused intravenously with high-dose corticosterone, and late-distal tubules were perfused orthogradely with artificial tubular fluid containing [14C]inulin and 22Na; urinary recoveries of the radioisotopes were monitored. Half of the rats received intravenous carbenoxolone to inhibit renal 11beta-HSD activity. The urinary recovery of [14C]inulin was complete in both groups of animals (101+/-2% versus 101+/-3%), but the recovery of 22Na was lower in carbenoxolone-treated rats (34+/-5%) than in the corticosterone-alone group (54+/-4%, P<0.01). These data, which provide the first demonstration of enhanced Na+ reabsorption in the distal nephron during inhibition of renal 11beta-HSD in vivo, strongly support the proposal that 11beta-HSD normally prevents endogenous glucocorticoid from exerting mineralocorticoid-like effects.
Bailey
M A
MA
Centre for Nephrology, Institute of Urology and Nephrology, Middlesex Hospital, Mortimer Street, London W1N 8AA, UK.
Unwin
R J
RJ
Shirley
D G
DG
D000042:Absorption; D000315:Adrenalectomy; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D002229:Carbenoxolone / Q000494:pharmacology; D002250:Carbon Radioisotopes / Q000378:metabolism; D003345:Corticosterone / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors / Q000502:physiology*; D007685:Kidney Tubules, Collecting / Q000378:metabolism*; D010783:Photometry; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000493:pharmacokinetics*; D012979:Sodium Radioisotopes / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D002250:Carbon Radioisotopes; D004791:Enzyme Inhibitors; D012979:Sodium Radioisotopes; D012964:Sodium; D006913:Hydroxysteroid Dehydrogenases; D002229:Carbenoxolone; D003345:Corticosterone